IP Library Granted Patent US 7,780,678
Granted Patent B2
US 7,780,678 · App. 10/640,131 · Granted Aug 24, 2010

Thermal treatment to improve intraocular lens inserter lubricity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,780,678
App. No.
10/640,131
Granted
Aug 24, 2010
Kind
B2
Abstract

Methods for enhancing the lubricity of implant delivery devices are provided. The present methods of enhancing the lubricity of an intraocular lens inserter reduce the force required to express an intraocular lens therefrom. By reducing the force required to express an intraocular lens from an inserter, intraocular lens delivery is improved.

Claims (28)

1. An intraocular lens inserter tip with enhanced lubricity comprising predominately one or more lower melting point polymorphs of one or more lubricants at a surface of the intraocular lens inserter tip, wherein material scraped from the surface of the intraocular lens inserter tip exhibits a DSC endotherm of from 68.8 to 73, and the lower melting point polymorphs form by melting corresponding higher melting point polymorphs of the one or more lubricants.

2. The intraocular inserter tip of claim 1 wherein said lubricants are selected from the group consisting of glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monostearate, glyceryl monoarachidate, glyceryl monobehenate, glyceryl monolignocerate, glyceryl monomontanate and combinations thereof.

3. The intraocular inserter tip of claim 1 wherein said one or more lower melting point polymorphs are selected from the group consisting of alpha polymorphs of monoglycerides.

4. The intraocular inserter tip of claim 1 wherein said one or more lower melting point polymorphs is the alpha polymorph of glyceryl monostearate.

5. The intraocular inserter tip of claim 1 wherein said device contains polypropylene.

6. The intraocular inserter tip of claim 1 wherein said one or more lower melting point polymorphs reduce the force required to express an intraocular lens into an eye.

7. An intraocular lens inserter tip with enhanced lubricity comprising:

polypropylene and one or more lower melting point, alpha polymorphs of one or more monoglycerides present in the polypropylene, wherein the concentration of the one or more lower melting point polymorphs is predominantly greater than the corresponding higher melting point polymorphs of the one or more monoglycerides which are selected from the group consisting of glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monostearate, glyceryl monoarachidate, glyceryl monobehenate, glyceryl monolignocerate and glyceryl monomontanate, and material scraped from a surface of the polypropylene inserter tip exhibits a DSC endotherm of from 68.8 to 73.

8. The intraocular inserter tip of claim 7 wherein said one or more lower melting point polymorphs is the alpha polymorph of glyceryl monostearate.

9. An intraocular inserter prepared by a process comprising:

providing an intraocular inserter tip comprising a polymer selected from polypropylene or polycarbonate, and one or more lubricants; and

heat treating the intraocular inserter at a temperature from 60° C. to 90° C. for a time sufficient to convert a predominant amount of the beta-polymorph to the corresponding alpha-polymorph of the one or more lubricants, and to provide a surface material of the polypropylene inserter tip, which when physically scrapped from the tip exhibits a DSC endotherm of from 68.8 to 73.

10. The intraocular inserter of claim 9 wherein the one or more lubricants are glyceryl monoesters of a saturated fatty acid.

11. The intraocular inserter of claim 9 wherein the one or more lubricants are selected from the group consisting of glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monostearate, glyceryl monoarachidate, glyceryl monobehenate, glyceryl monolignocerate and glyceryl monomontanate.

12. The intraocular inserter of claim 9 wherein the one or more lubricants includes glyceryl monostearate.

13. The intraocular inserter of claim 12 wherein the heat treating is conducted at a temperature from 70° C. to 85° C. for a period of from fifteen minutes to four hours.

14. The intraocular inserter of claim 13 wherein sterilizing the intraocular inserter is conducted prior to the heat treating.

15. The intraocular inserter of claim 9 further comprising sterilizing the intraocular inserter by contacting the inserter with ethylene oxide.

16. The intraocular inserter of claim 15 wherein sterilizing the intraocular inserter is conducted prior to the heat treating.

17. The intraocular inserter of claim 15 wherein sterilizing the intraocular inserter is conducted after the heat treating.

18. The intraocular inserter of claim 9 wherein the heat treating is conducted at a temperature from 70° C. to 85° C. for a period of from fifteen minutes to four hours.

19. An intraocular inserter prepared by a process comprising:

providing an intraocular inserter tip comprising polypropylene and one or more glyceryl monoesters of a saturated fatty acid;

contacting the intraocular inserter with ethylene oxide; and

heat treating the intraocular inserter at a temperature from 60° C. to 90° C. for a time sufficient to convert a predominant amount of the beta-polymorph to the corresponding alpha-polymorph of the one or more glyceryl monoesters of a saturated fatty acid, and to provide a surface material of the polypropylene inserter tip, which when physically scrapped from the tip exhibits a DSC endotherm of from 68.8 to 73.

20. The intraocular inserter of claim 19 wherein the heat treating is conducted at a temperature from 70° C. to 85° C. for a period of from fifteen minutes to four hours.

21. The intraocular inserter of claim 20 wherein the one or more lubricants are selected from the group consisting of glyceryl monolaurate, glyceryl monomyristate, glyceryl monopalmitate, glyceryl monostearate, glyceryl monoarachidate, glyceryl monobehenate, glyceryl monolignocerate and glyceryl monomontanate.

22. The intraocular inserter of claim 20 wherein the one or more lubricants includes glyceryl monostearate.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →
RELEASE OF SECURITY INTEREST Recorded Aug 5, 2012
From: CREDIT SUISSE AG, CAYMAN ISLANDS BRANCH
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 028726/0142 →
SECURITY AGREEMENT Recorded Nov 1, 2010
From: WP PRISM INC.; BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; IOLAB CORPORATION; RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; EYEONICS, INC.
To: CREDIT SUISSE AG, AS ADMINISTRATIVE AGENT
Reel/Frame 025227/0143 →
SECURITY AGREEMENT Recorded Nov 16, 2007
From: BAUSCH & LOMB INCORPORATED; B&L CRL INC.; B&L CRL PARTNERS L.P.; B & L DOMESTIC HOLDINGS CORP.; B&L FINANCIAL HOLDINGS CORP.; B&L SPAF INC.; B&L VPLEX HOLDINGS, INC.; BAUSCH & LOMB CHINA, INC.; BAUSCH & LOMB INTERNATIONAL INC.; BAUSCH & LOMB TECHNOLOGY CORPORATION; BAUSCH & LOMB REALTY CORPORATION; BAUSCH & LOMB SOUTH ASIA, INC.; SIGHT SAVERS, INC.; WILMINGTON MANAGEMENT CORP.; WILMINGTON PARTNERS L.P.; B&L MINORITY DUTCH HOLDINGS LLC; IOLAB CORPORATION; RHC HOLDINGS, INC.; WP PRISM, INC.
To: CREDIT SUISSE
Reel/Frame 020122/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 7, 2004
From: VANDERBILT, DAVID P.; TSOU, LI-CHUN
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 014238/0227 →